BackImmix Biopharma Overview

Immix Biopharma Long Term Debt

Track Immix Biopharma's long-term debt ($910K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$912343.00
↓ 7.95% YoYΔ $-78783.00 vs prior year quarter

Peer average

Loading

Immix Biopharma Long Term Debt History

Loading

Immix Biopharma vs. peers: Long Term Debt Comparison

Loading

Immix Biopharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immix Biopharma (IMMX) FAQ

Immix Biopharma (IMMX) currently reports a long-term debt of $910K as of March 2026. That compares with $990K in the prior-year period — down 7.9% year over year. Use the charts on this page to explore Immix Biopharma's long-term debt history and peer comparisons.

Immix Biopharma's long-term debt decreased from $990K to $910K — a 7.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immix Biopharma reported $910K in long-term debt as of March 2026. That compares with $990K in the prior-year period — down 7.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $910K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immix Biopharma, and consider following IMMX for alerts when major investors trade the stock.